GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 40 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 42 | |
P/E GROWTH RATING 1..100 | 89 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FICS | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 71% | N/A |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 44% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 68% |
| MACD ODDS (%) | 2 days ago 83% | N/A |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 76% | 2 days ago 58% |
| Advances ODDS (%) | 3 days ago 81% | 2 days ago 61% |
| Declines ODDS (%) | 9 days ago 81% | 8 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 43% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 53% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ZEMIX | 12.34 | 0.05 | +0.41% |
| American Beacon Ninety One Emr Mkts EqR5 | |||
| LMPIX | 35.58 | 0.10 | +0.28% |
| ClearBridge Appreciation FI | |||
| PJIQX | 15.49 | 0.04 | +0.26% |
| PGIM Jennison Global Equity Income R6 | |||
| DWGHX | 13.88 | 0.03 | +0.22% |
| American Funds Dvlpg Wld Gr&Inc F2 | |||
| EVCGX | 18.01 | -0.03 | -0.17% |
| Eaton Vance China Equity A | |||
A.I.dvisor indicates that over the last year, FICS has been closely correlated with SLF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if FICS jumps, then SLF could also see price increases.
| Ticker / NAME | Correlation To FICS | 1D Price Change % | ||
|---|---|---|---|---|
| FICS | 100% | -0.01% | ||
| SLF - FICS | 67% Closely correlated | -0.08% | ||
| BMO - FICS | 64% Loosely correlated | +0.13% | ||
| TD - FICS | 62% Loosely correlated | +0.43% | ||
| SAN - FICS | 59% Loosely correlated | +0.51% | ||
| GSK - FICS | 56% Loosely correlated | +0.23% | ||
More | ||||
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.